Search Results 551-560 of 13475 for Birth Control Palette

  1. Mayo Clinic

    Leslie Cooper, M.D., Mayo Clinic Cardiology: He had rapid re-narrowing to the arteries to his heart after they had placed stents. In his case, they were related ...

  2. Obstetrics and Gynecology Clinical Trials - Medical Professionals

    A Study to Assess Maternal and Fetal Outcomes in Pregnancy with Type 1 Diabetes Mellitus and Controls. Rochester, Minn. The purpose of this study is to ...

  3. A Study of Ovarian Tissue Freezing for the Preservation of Fertility in Children - Mayo Clinic

    The purpose of this study is to offer ovarian tissue cryopreservation to female pediatric patients (birth-17 years of age) with fertility threatening ...

  4. Labor and delivery, postpartum care

    You may have mood swings. You might be cranky, sad and anxious. These feelings are common. Some people get postpartum depression after giving birth. You might ...

  5. A Study Comparing Gemcitabine with or without AZD 1775 in Treating Patients with Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer - Mayo Clinic

    ... contraception (hormonal or barrier method of birth control; abstinence) prior to study entry and for the duration of study participation. If a woman ...

  6. Nivolumab and Brentuximab Vedotin After Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Classical Hodgkin Lymphoma - Mayo Clinic

    Male: use two effective methods of contraception (barrier method) or abstain from heterosexual activity with the first dose of study therapy through 7 months ...

  7. Labor and delivery, postpartum care

    You may have mood swings. You might be cranky, sad and anxious. These feelings are common. Some people get postpartum depression after giving birth. You might ...

  8. A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Crohn's Disease Who Completed the Studies M14-431 or M14-433 - Mayo Clinic

    ... birth control that is effective from Baseline Visit through at least 30 days after the last dose of study drug. Subjects must voluntarily sign and date an ...

  9. Assessing Pre-existing Antibodies to AAV in a Population of Patients With PKP2-Associated ARVC - Mayo Clinic

    About this study. The purpose of this multicenter, seroprevalence study to assess pre-existing antibodies to Adenovirus-associated Virus Vector (AAV) in a ...

  10. Study of Tipifarnib in Subjects With Relapsed or Refractory Peripheral T-Cell Lymphoma - Mayo Clinic

    Both females and male subjects with female partners of child-bearing potential must agree to use an adequate method of contraception for 2 weeks prior to ...